NeuroTherapia was formed as a Cleveland Clinic spin-off with an initial investment from the Cleveland Clinic Foundation. The Company closed it Series A round, led by Brain Trust Accelerator Fund II, included investments from The Cleveland Clinic Foundation, Dolby Family Ventures and Alzheimer's Drug Discovery Foundation in 2021.

​

In August of 2024, the Company had the first close of its Series B financing, which was led by Cleveland Clinic Foundation, with all previous investors participating in the round, and which included new investments from Foundation For A Better World and CRUINT.

​

The Company has also received grants from the Alzheimer’s Association and the the State of Ohio’s Department of Development’s Technology Venture Accelerator Fund.